References
- Bondesen S, et al. 5-aminosalicyclic acid in the treatment of inflammatory bowel disease. Acta Med Scand 1987; 221–227
- Klotz U, et al. Pharmacology and pharmacokinetics of 5-aminosalicylic acid. Dig Dis Sci 1987; 32: 46S
- Chan R P, et al. Studies of two novel sulfasalazine analogs. Dig Dis Sci 1983; 23: 609
- Brown J P, et al. A polymeric drug for treatment of inflammatory bowel disease. J Med Chem 1983; 26: 1300
- Rasmussen S W, et al. 5-AS A in a slow release preparation: Bioavailability, plasma level and excretion in humans. Gastroenterology 1982; 83: 1062
- Martin F, et al. Oral 5-ASA preparations in treatment of inflammatory bowel disease. Dig Dis Sci 1987; 32: 57S
- Osterwald HP. Properties of film-formers and their use in aqueous systems. Pharm Res 1985; 1: 14
- Chambliss WG. The forgotten dosage form: enteric coated tablets. Pharm Technol 1983; 7: 124
- Dew M J, et al. An oral preparation to release drug in the human colon. Br J Clin Pharmacol 1982; 14: 405
- Hardy J G, et al. Evaluation of an enteric-coated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease. Aliment Pharmacol Ther 1987; 1: 273